Intel CEO Pat Gelsinger Under Growing Pressure As Chipmaker Evaluates Major AI Strategy Overhaul To Catch Up With Nvidia And AMD: Report

Full Article
Intel CEO Pat Gelsinger Under Growing Pressure As Chipmaker Evaluates Major AI Strategy Overhaul To Catch Up With Nvidia And AMD: Report

Intel is under pressure to revamp its AI strategy as it struggles in the competitive chip market. CEO Pat Gelsinger is evaluating significant changes to regain market share against rivals Nvidia and AMD. The board's directive to focus on AI has led to the establishment of an AI Acceleration office, but Intel still lags in sales.

Despite the introduction of new products like the Gaudi 3 chips, Intel's sales projections are far behind Nvidia's multibillion-dollar figures. The company is also facing internal challenges, including executive departures and a declining stock price. Gelsinger's upcoming comprehensive plan will address asset sales and cost reductions to navigate these turbulent times.

• Intel is evaluating major changes to its AI strategy to regain competitiveness.

• Gelsinger faces scrutiny as Intel's market value drops significantly.

Key AI Terms Mentioned in this Article

AI Strategy

Intel's board is pushing for a stronger focus on AI to improve competitiveness.

AI Chip

Intel's Gaudi 3 chips are an example, but they are not performing as well as competitors' offerings.

IPO

Intel is considering an IPO for its Altera unit as part of its strategic overhaul.

Companies Mentioned in this Article

Intel

Intel is currently facing challenges in the AI chip market and is exploring strategic changes.

Nvidia

Nvidia has significantly outperformed Intel in AI chip sales, contributing to Intel's competitive pressure.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics